VelaLabs GmbH under new management
Times are changing and so are we – VelaLabs has grown up and is now moving into the next evolving step of the organizati…
Times are changing and so are we – VelaLabs has grown up and is now moving into the next evolving step of the organizati…
Expansion adds development and manufacturing capacity for pre-clinical, clinical and commercial supply of bioconjugates…
Curexsys GmbH, a leader in the emerging field of therapeutic exosomes, today announced the appointment of Christian Ecke…
Tubulis today announced the appointment of Dr. Christian Grøndahl, as the inaugural Chairman of the company’s Supervisor…
. - John Tchelingerian, PhD (Chair), Dharminder Singh Chahal and Prof. Dr. Chris Bangma to form Supervisory Board Pan…
The new year begins, Peli Products is getting ready to commemorate its 45th year in business and commitment to its visio…
Two new bioconjugation suites to provide high throughput conjugation for the commercialization of antibody-drug conjuga…
Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and develop…
Lonza’s Ibex™ Design planned to take Genmab’s pre-clinical candidates from gene to potential IND within 12 months Lonza’…
Marc Wolff has been named Chief Financial Officer of Aldevron, a leading global provider of plasmid DNA manufacturing, p…